Dr. Chan has developed innovative microfluidic technologies to perform 3D spheroid culture of mesenchymal stem cells and hepatocytes and examined the functional role of specific extracellular matrix components. He will be applying his expertise to establish a microphysiological system containing a 3D human skeletal muscle tissue (3DSM) by culturing primary human myoblast in a fibrin-based hydrogel for a biomimetic platform drug toxicity testing.
